JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 18, 2008; DOI: 10.1124/jpet.108.140186


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.108.140186v1
326/3/700    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Almon, R. R.
Right arrow Articles by Jusko, W. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almon, R. R.
Right arrow Articles by Jusko, W. J.


Received for publication April 17, 2008.
Revised May 23, 2008.
Accepted for publication May 27, 2008.

Circadian Variations in Liver Gene Expression: Relationships to Drug Actions

Richard R. Almon 1*, Eric Yang 2, William Lai 3, Ioannis P Androulakis 2, Debra C DuBois 3, William J. Jusko 1

1 State University of New York - Buffalo 2 Rutgers University 3 State University of New York at Buffalo

* Address correspondence to: E-mail: almon{at}eng.buffalo.edu

Abstract

Chronopharmacology is an important but under-explored aspect of therapeutics. Rhythmic variations in biological processes can influence drug action, including pharmacodynamic responses, due to circadian variations in the availability or functioning of drug targets. We hypothesized that global gene expression analysis can be useful in the identification of circadian regulated genes involved in drug action. Circadian variations in gene expression in rat liver were explored using Affymetrix gene arrays. A rich time series involving animals analyzed at 18 time points within the 24 hour cycle was generated. Of the more than 15,000 probe sets on these arrays, 265 exhibited oscillations with a 24 hour frequency. Cluster analysis yielded 5 distinct circadian clusters, with approximately two-thirds of the transcripts reaching maximum expression during the animal's dark/active period. Of the 265 probe sets, 107 of potential therapeutic importance were identified. The expression levels of clock genes were also investigated in this study. Five clock genes exhibited circadian variation in liver, and data suggest that these genes may also be regulated by corticosteroids.


Key words: cancer, cholesterol biosynthesis, chronopharmacology, circadian rhythms, gene expression profiling, glucocorticoids





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.